Aehr VP Alistair Sporck sells $201,916 in company stock
Aehr Test Systems' VP of Contactor Business Unit, Alistair N. Sporck, sold 2,000 shares of the company's common stock on August 4, 2026. The sale took place in multiple transactions at prices between $100.695 and $101.10 per share, totaling $201,916. As a result of these sales, Sporck now directly holds 23,547 AEHR shares, including those subject to unvested restricted stock units.
Indirectly, he owns 5,177 shares through a trust. Notably, this sale occurred as AEHR stock has experienced a significant surge since August, currently trading at $134.06, a 30% gain from the sale price. Over the past year, the stock has delivered a 632% gain, and year-to-date, it has returned 564%. According to InvestingPro analysis, AEHR appears overvalued relative to its Fair Value, ranking among the most overvalued stocks in the market.
Investors can find further insights through 18 additional InvestingPro Tips and a comprehensive Pro Research Report. Meanwhile, Aehr Test Systems reported strong fiscal fourth-quarter earnings, surpassing analyst expectations with adjusted earnings of $0.11 per share on $18.8 million in revenue. The company also reported record quarterly bookings of $60.7 million, elevating its backlog to over $100 million.
Furthermore, Aehr secured a $22 million production order from a key wafer-level AI processor customer, supporting capacity expansion with multiple fully automated FOX-XP wafer-level burn-in systems. The order is expected to be fulfilled over the next six months. Additionally, the company received another production order from a silicon photonics customer for a fully automated FOX-XP multi-wafer production burn-in system, with shipment anticipated in the first half of 2027.
Analysts have taken note, with Jefferies and Freedom Broker upgrading the stock to "Buy" ratings and raising the price target to $110. Aehr Test Systems is shifting focus from silicon carbide to AI, with AI projected to account for over 90% of revenue by fiscal year 2026.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.